GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
50.75
-0.46 (-0.90%)
Oct 23, 2026, 4:00 PM EDT - Market closed

GSK Revenue

GSK had revenue of 8.41B GBP in the quarter ending June 30, 2026, with 5.30% growth. This brings the company's total for the last twelve months to 33.20B, up 4.97% year-over-year. In the year 2025, GSK had annual revenue of 32.67B with 4.11% growth.

Revenue (ttm)
33.20B GBP
Revenue Growth
+4.97%
P/S Ratio
2.30
Revenue / Employee
496,746 GBP
Employees
66,841
Market Cap
101.52B USD

Revenue Chart

* This company reports financials in GBP.

Revenue by Segment

By Segment

Chart
  • HIV 7.69B 23.5%
  • Respiratory 7.07B 21.6%
  • Respiratory, Immunology and Inflammation 3.81B 11.7%
  • Shingles 3.56B 10.9%
  • Other Paediatric & Adult Vaccines 3.12B 9.6%
  • Other General Medicines 2.97B 9.1%
  • Oncology 1.98B 6.1%
  • Other 2.48B 7.6%

By Geography

Chart
  • US 16.86B 51.6%
  • International 8.28B 25.3%
  • Europe 7.53B 23.1%
Fiscal year ended Dec 31, 2025 See the full GSK breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202532.67B1.29B4.11%
Dec 31, 202431.38B1.05B3.46%
Dec 31, 202330.33B1.00B3.42%
Dec 31, 202229.32B4.63B18.74%
Dec 31, 202124.70B-9.40B-27.58%
Dec 31, 202034.10B345.00M1.02%
Dec 31, 201933.75B2.93B9.52%
Dec 31, 201830.82B635.00M2.10%
Dec 31, 201730.19B2.30B8.24%
Dec 31, 201627.89B3.97B16.58%
Dec 31, 201523.92B917.00M3.99%
Dec 31, 201423.01B-3.50B-13.20%
Dec 31, 201326.51B74.00M0.28%
Dec 31, 201226.43B-956.00M-3.49%
Dec 31, 201127.39B-1.01B-3.54%
Dec 31, 201028.39B24.00M0.08%
Dec 31, 200928.37B4.02B16.49%
Dec 31, 200824.35B1.64B7.20%
Dec 31, 200722.72B-509.00M-2.19%
Dec 31, 200623.23B1.57B7.23%
Dec 31, 200521.66B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Merck & Co.66.57B
AbbVie64.39B
Pfizer63.70B
AstraZeneca61.37B
Novartis AG56.69B
Sanofi55.89B
Novo Nordisk50.34B
Bristol-Myers Squibb Company49.19B
Revenue Rankings